REHEPTIN UD 300

About

Ursodeoxycholic Acid (UDCA), the active ingredient in REHEPTIN UD 300, is a naturally occurring bile acid that plays a crucial role in the management of various cholestatic liver diseases and for the dissolution of certain types of gallstones. It functions by altering the composition of bile, specifically by reducing the cholesterol content and increasing the proportion of UDCA, which is less toxic to liver cells than other endogenous bile acids. This action helps to protect hepatocytes from damage and improves bile flow, thereby enhancing overall liver function in affected individuals.

REHEPTIN UD 300 is particularly indicated for conditions such as primary biliary cholangitis (PBC), where it can slow disease progression, improve liver enzyme levels, and alleviate symptoms like pruritus. It is also used for the dissolution of small to medium-sized, non-calcified cholesterol gallstones in patients who are not suitable candidates for surgical intervention. The 300mg formulation allows for flexible dosing, typically administered once or twice daily, and its therapeutic benefits are achieved through its cytoprotective, immunomodulatory, and anticholestatic properties.

Uses

• Dissolution of small to medium-sized cholesterol gallstones.
• Treatment of primary biliary cholangitis (PBC).
• Management of cholestatic liver diseases.
• Prevention of gallstone formation during rapid weight loss.

Directions For Use

Take orally with food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Helps dissolve cholesterol gallstones effectively.
• Improves liver function in cholestatic conditions.
• Reduces symptoms associated with primary biliary cholangitis.
• Protects liver cells from toxic bile acids.
• May slow the progression of certain liver diseases.
• Enhances bile flow and reduces bile stasis.

Side Effects

• Diarrhea
• Nausea
• Abdominal pain
• Constipation
• Indigestion
• Headache
• Dizziness
• Back pain
• Hair thinning
• Rash
• Fatigue
• Vomiting

Safety Measures

• Alcohol - Alcohol consumption should be avoided or minimized as it can exacerbate liver conditions and potentially interfere with the medication's efficacy.
• Pregnancy - Use during pregnancy is generally not recommended unless clearly necessary and the potential benefits outweigh the risks, as data on human pregnancy is limited.
• Breastfeeding - Small amounts of UDCA may pass into breast milk. Consult a doctor; generally considered safe but monitor the infant for adverse effects.
• Liver - While used for liver conditions, caution is advised in severe liver impairment or acute liver inflammation. Regular liver function tests are essential.
• Kidney - No specific dose adjustment is typically required for kidney impairment, but use with caution in severe renal disease.
• Lung - No direct contraindications or specific safety concerns related to lung conditions are generally noted for this medication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.